The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Tetanus Vaccine (Adsorbed) Market Research Report 2025
Synopsis
Tetanus Vaccine (Adsorbed) is a preparation of Tetanus formol toxoid adsorbed on aluminium phosphate gel. Thiomersal is used as a preservative. The potency is not less than 40 International Units per single human dose.
The global Tetanus Vaccine (Adsorbed) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Tetanus Vaccine (Adsorbed) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tetanus Vaccine (Adsorbed) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Tetanus Vaccine (Adsorbed) include Sanofi Pasteur, GSK, Bio Farma, Serum Institute of India, Panacea Biotec, Mitsubishi Tanabe Pharma, KM Biologics, MassBiologics, Chengdu Oulin Biological, Hualan Biological Bacterin, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tetanus Vaccine (Adsorbed), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tetanus Vaccine (Adsorbed).
The Tetanus Vaccine (Adsorbed) market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Tetanus Vaccine (Adsorbed) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tetanus Vaccine (Adsorbed) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Sanofi Pasteur
GSK
Bio Farma
Serum Institute of India
Panacea Biotec
Mitsubishi Tanabe Pharma
KM Biologics
MassBiologics
Chengdu Oulin Biological
Hualan Biological Bacterin
Wuhan Biological Products
Segment by Type
Tetanus Vaccine
Combined Vaccine
Segment by Application
Children
Teenager
Adult
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tetanus Vaccine (Adsorbed) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tetanus Vaccine (Adsorbed) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Tetanus Vaccine (Adsorbed) is a preparation of Tetanus formol toxoid adsorbed on aluminium phosphate gel. Thiomersal is used as a preservative. The potency is not less than 40 International Units per single human dose.
The global Tetanus Vaccine (Adsorbed) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Tetanus Vaccine (Adsorbed) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tetanus Vaccine (Adsorbed) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Tetanus Vaccine (Adsorbed) include Sanofi Pasteur, GSK, Bio Farma, Serum Institute of India, Panacea Biotec, Mitsubishi Tanabe Pharma, KM Biologics, MassBiologics, Chengdu Oulin Biological, Hualan Biological Bacterin, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tetanus Vaccine (Adsorbed), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tetanus Vaccine (Adsorbed).
The Tetanus Vaccine (Adsorbed) market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Tetanus Vaccine (Adsorbed) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tetanus Vaccine (Adsorbed) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Sanofi Pasteur
GSK
Bio Farma
Serum Institute of India
Panacea Biotec
Mitsubishi Tanabe Pharma
KM Biologics
MassBiologics
Chengdu Oulin Biological
Hualan Biological Bacterin
Wuhan Biological Products
Segment by Type
Tetanus Vaccine
Combined Vaccine
Segment by Application
Children
Teenager
Adult
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tetanus Vaccine (Adsorbed) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tetanus Vaccine (Adsorbed) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Tetanus Vaccine (Adsorbed) Market Overview
1.1 Product Definition
1.2 Tetanus Vaccine (Adsorbed) by Type
1.2.1 Global Tetanus Vaccine (Adsorbed) Market Value Comparison by Type (2024-2030)
1.2.2 Tetanus Vaccine
1.2.3 Combined Vaccine
1.3 Tetanus Vaccine (Adsorbed) by Application
1.3.1 Global Tetanus Vaccine (Adsorbed) Market Value by Application (2024-2030)
1.3.2 Children
1.3.3 Teenager
1.3.4 Adult
1.4 Global Tetanus Vaccine (Adsorbed) Market Size Estimates and Forecasts
1.4.1 Global Tetanus Vaccine (Adsorbed) Revenue 2019-2030
1.4.2 Global Tetanus Vaccine (Adsorbed) Sales 2019-2030
1.4.3 Global Tetanus Vaccine (Adsorbed) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Tetanus Vaccine (Adsorbed) Market Competition by Manufacturers
2.1 Global Tetanus Vaccine (Adsorbed) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Tetanus Vaccine (Adsorbed) Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Tetanus Vaccine (Adsorbed), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tetanus Vaccine (Adsorbed), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tetanus Vaccine (Adsorbed), Product Type & Application
2.7 Global Key Manufacturers of Tetanus Vaccine (Adsorbed), Date of Enter into This Industry
2.8 Global Tetanus Vaccine (Adsorbed) Market Competitive Situation and Trends
2.8.1 Global Tetanus Vaccine (Adsorbed) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Tetanus Vaccine (Adsorbed) Players Market Share by Revenue
2.8.3 Global Tetanus Vaccine (Adsorbed) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tetanus Vaccine (Adsorbed) Market Scenario by Region
3.1 Global Tetanus Vaccine (Adsorbed) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Tetanus Vaccine (Adsorbed) Sales by Region: 2019-2030
3.2.1 Global Tetanus Vaccine (Adsorbed) Sales by Region: 2019-2024
3.2.2 Global Tetanus Vaccine (Adsorbed) Sales by Region: 2025-2030
3.3 Global Tetanus Vaccine (Adsorbed) Revenue by Region: 2019-2030
3.3.1 Global Tetanus Vaccine (Adsorbed) Revenue by Region: 2019-2024
3.3.2 Global Tetanus Vaccine (Adsorbed) Revenue by Region: 2025-2030
3.4 North America Tetanus Vaccine (Adsorbed) Market Facts & Figures by Country
3.4.1 North America Tetanus Vaccine (Adsorbed) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Tetanus Vaccine (Adsorbed) Sales by Country (2019-2030)
3.4.3 North America Tetanus Vaccine (Adsorbed) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tetanus Vaccine (Adsorbed) Market Facts & Figures by Country
3.5.1 Europe Tetanus Vaccine (Adsorbed) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Tetanus Vaccine (Adsorbed) Sales by Country (2019-2030)
3.5.3 Europe Tetanus Vaccine (Adsorbed) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tetanus Vaccine (Adsorbed) Market Facts & Figures by Region
3.6.1 Asia Pacific Tetanus Vaccine (Adsorbed) Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Tetanus Vaccine (Adsorbed) Sales by Region (2019-2030)
3.6.3 Asia Pacific Tetanus Vaccine (Adsorbed) Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Tetanus Vaccine (Adsorbed) Market Facts & Figures by Country
3.7.1 Latin America Tetanus Vaccine (Adsorbed) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Tetanus Vaccine (Adsorbed) Sales by Country (2019-2030)
3.7.3 Latin America Tetanus Vaccine (Adsorbed) Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Tetanus Vaccine (Adsorbed) Market Facts & Figures by Country
3.8.1 Middle East and Africa Tetanus Vaccine (Adsorbed) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Tetanus Vaccine (Adsorbed) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Tetanus Vaccine (Adsorbed) Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tetanus Vaccine (Adsorbed) Sales by Type (2019-2030)
4.1.1 Global Tetanus Vaccine (Adsorbed) Sales by Type (2019-2024)
4.1.2 Global Tetanus Vaccine (Adsorbed) Sales by Type (2025-2030)
4.1.3 Global Tetanus Vaccine (Adsorbed) Sales Market Share by Type (2019-2030)
4.2 Global Tetanus Vaccine (Adsorbed) Revenue by Type (2019-2030)
4.2.1 Global Tetanus Vaccine (Adsorbed) Revenue by Type (2019-2024)
4.2.2 Global Tetanus Vaccine (Adsorbed) Revenue by Type (2025-2030)
4.2.3 Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Type (2019-2030)
4.3 Global Tetanus Vaccine (Adsorbed) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Tetanus Vaccine (Adsorbed) Sales by Application (2019-2030)
5.1.1 Global Tetanus Vaccine (Adsorbed) Sales by Application (2019-2024)
5.1.2 Global Tetanus Vaccine (Adsorbed) Sales by Application (2025-2030)
5.1.3 Global Tetanus Vaccine (Adsorbed) Sales Market Share by Application (2019-2030)
5.2 Global Tetanus Vaccine (Adsorbed) Revenue by Application (2019-2030)
5.2.1 Global Tetanus Vaccine (Adsorbed) Revenue by Application (2019-2024)
5.2.2 Global Tetanus Vaccine (Adsorbed) Revenue by Application (2025-2030)
5.2.3 Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Application (2019-2030)
5.3 Global Tetanus Vaccine (Adsorbed) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Company Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur Tetanus Vaccine (Adsorbed) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Pasteur Tetanus Vaccine (Adsorbed) Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Tetanus Vaccine (Adsorbed) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Tetanus Vaccine (Adsorbed) Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Bio Farma
6.3.1 Bio Farma Company Information
6.3.2 Bio Farma Description and Business Overview
6.3.3 Bio Farma Tetanus Vaccine (Adsorbed) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bio Farma Tetanus Vaccine (Adsorbed) Product Portfolio
6.3.5 Bio Farma Recent Developments/Updates
6.4 Serum Institute of India
6.4.1 Serum Institute of India Company Information
6.4.2 Serum Institute of India Description and Business Overview
6.4.3 Serum Institute of India Tetanus Vaccine (Adsorbed) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Serum Institute of India Tetanus Vaccine (Adsorbed) Product Portfolio
6.4.5 Serum Institute of India Recent Developments/Updates
6.5 Panacea Biotec
6.5.1 Panacea Biotec Company Information
6.5.2 Panacea Biotec Description and Business Overview
6.5.3 Panacea Biotec Tetanus Vaccine (Adsorbed) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Panacea Biotec Tetanus Vaccine (Adsorbed) Product Portfolio
6.5.5 Panacea Biotec Recent Developments/Updates
6.6 Mitsubishi Tanabe Pharma
6.6.1 Mitsubishi Tanabe Pharma Company Information
6.6.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.6.3 Mitsubishi Tanabe Pharma Tetanus Vaccine (Adsorbed) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Mitsubishi Tanabe Pharma Tetanus Vaccine (Adsorbed) Product Portfolio
6.6.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.7 KM Biologics
6.7.1 KM Biologics Company Information
6.7.2 KM Biologics Description and Business Overview
6.7.3 KM Biologics Tetanus Vaccine (Adsorbed) Sales, Revenue and Gross Margin (2019-2024)
6.7.4 KM Biologics Tetanus Vaccine (Adsorbed) Product Portfolio
6.7.5 KM Biologics Recent Developments/Updates
6.8 MassBiologics
6.8.1 MassBiologics Company Information
6.8.2 MassBiologics Description and Business Overview
6.8.3 MassBiologics Tetanus Vaccine (Adsorbed) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 MassBiologics Tetanus Vaccine (Adsorbed) Product Portfolio
6.8.5 MassBiologics Recent Developments/Updates
6.9 Chengdu Oulin Biological
6.9.1 Chengdu Oulin Biological Company Information
6.9.2 Chengdu Oulin Biological Description and Business Overview
6.9.3 Chengdu Oulin Biological Tetanus Vaccine (Adsorbed) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Chengdu Oulin Biological Tetanus Vaccine (Adsorbed) Product Portfolio
6.9.5 Chengdu Oulin Biological Recent Developments/Updates
6.10 Hualan Biological Bacterin
6.10.1 Hualan Biological Bacterin Company Information
6.10.2 Hualan Biological Bacterin Description and Business Overview
6.10.3 Hualan Biological Bacterin Tetanus Vaccine (Adsorbed) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hualan Biological Bacterin Tetanus Vaccine (Adsorbed) Product Portfolio
6.10.5 Hualan Biological Bacterin Recent Developments/Updates
6.11 Wuhan Biological Products
6.11.1 Wuhan Biological Products Company Information
6.11.2 Wuhan Biological Products Description and Business Overview
6.11.3 Wuhan Biological Products Tetanus Vaccine (Adsorbed) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Wuhan Biological Products Tetanus Vaccine (Adsorbed) Product Portfolio
6.11.5 Wuhan Biological Products Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tetanus Vaccine (Adsorbed) Industry Chain Analysis
7.2 Tetanus Vaccine (Adsorbed) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tetanus Vaccine (Adsorbed) Production Mode & Process
7.4 Tetanus Vaccine (Adsorbed) Sales and Marketing
7.4.1 Tetanus Vaccine (Adsorbed) Sales Channels
7.4.2 Tetanus Vaccine (Adsorbed) Distributors
7.5 Tetanus Vaccine (Adsorbed) Customers
8 Tetanus Vaccine (Adsorbed) Market Dynamics
8.1 Tetanus Vaccine (Adsorbed) Industry Trends
8.2 Tetanus Vaccine (Adsorbed) Market Drivers
8.3 Tetanus Vaccine (Adsorbed) Market Challenges
8.4 Tetanus Vaccine (Adsorbed) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Tetanus Vaccine (Adsorbed) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Tetanus Vaccine (Adsorbed) Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Tetanus Vaccine (Adsorbed) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Tetanus Vaccine (Adsorbed) Sales (K Dose) of Key Manufacturers (2019-2024)
Table 5. Global Tetanus Vaccine (Adsorbed) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Tetanus Vaccine (Adsorbed) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Tetanus Vaccine (Adsorbed) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Tetanus Vaccine (Adsorbed) Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Tetanus Vaccine (Adsorbed), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Tetanus Vaccine (Adsorbed), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Tetanus Vaccine (Adsorbed), Product Type & Application
Table 12. Global Key Manufacturers of Tetanus Vaccine (Adsorbed), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tetanus Vaccine (Adsorbed) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tetanus Vaccine (Adsorbed) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tetanus Vaccine (Adsorbed) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Tetanus Vaccine (Adsorbed) Sales by Region (2019-2024) & (K Dose)
Table 18. Global Tetanus Vaccine (Adsorbed) Sales Market Share by Region (2019-2024)
Table 19. Global Tetanus Vaccine (Adsorbed) Sales by Region (2025-2030) & (K Dose)
Table 20. Global Tetanus Vaccine (Adsorbed) Sales Market Share by Region (2025-2030)
Table 21. Global Tetanus Vaccine (Adsorbed) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Region (2019-2024)
Table 23. Global Tetanus Vaccine (Adsorbed) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Region (2025-2030)
Table 25. North America Tetanus Vaccine (Adsorbed) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Tetanus Vaccine (Adsorbed) Sales by Country (2019-2024) & (K Dose)
Table 27. North America Tetanus Vaccine (Adsorbed) Sales by Country (2025-2030) & (K Dose)
Table 28. North America Tetanus Vaccine (Adsorbed) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Tetanus Vaccine (Adsorbed) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Tetanus Vaccine (Adsorbed) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Tetanus Vaccine (Adsorbed) Sales by Country (2019-2024) & (K Dose)
Table 32. Europe Tetanus Vaccine (Adsorbed) Sales by Country (2025-2030) & (K Dose)
Table 33. Europe Tetanus Vaccine (Adsorbed) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Tetanus Vaccine (Adsorbed) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Tetanus Vaccine (Adsorbed) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Tetanus Vaccine (Adsorbed) Sales by Region (2019-2024) & (K Dose)
Table 37. Asia Pacific Tetanus Vaccine (Adsorbed) Sales by Region (2025-2030) & (K Dose)
Table 38. Asia Pacific Tetanus Vaccine (Adsorbed) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Tetanus Vaccine (Adsorbed) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Tetanus Vaccine (Adsorbed) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Tetanus Vaccine (Adsorbed) Sales by Country (2019-2024) & (K Dose)
Table 42. Latin America Tetanus Vaccine (Adsorbed) Sales by Country (2025-2030) & (K Dose)
Table 43. Latin America Tetanus Vaccine (Adsorbed) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Tetanus Vaccine (Adsorbed) Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Tetanus Vaccine (Adsorbed) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Tetanus Vaccine (Adsorbed) Sales by Country (2019-2024) & (K Dose)
Table 47. Middle East and Africa Tetanus Vaccine (Adsorbed) Sales by Country (2025-2030) & (K Dose)
Table 48. Middle East and Africa Tetanus Vaccine (Adsorbed) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Tetanus Vaccine (Adsorbed) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Tetanus Vaccine (Adsorbed) Sales (K Dose) by Type (2019-2024)
Table 51. Global Tetanus Vaccine (Adsorbed) Sales (K Dose) by Type (2025-2030)
Table 52. Global Tetanus Vaccine (Adsorbed) Sales Market Share by Type (2019-2024)
Table 53. Global Tetanus Vaccine (Adsorbed) Sales Market Share by Type (2025-2030)
Table 54. Global Tetanus Vaccine (Adsorbed) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Tetanus Vaccine (Adsorbed) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Type (2019-2024)
Table 57. Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Type (2025-2030)
Table 58. Global Tetanus Vaccine (Adsorbed) Price (US$/Dose) by Type (2019-2024)
Table 59. Global Tetanus Vaccine (Adsorbed) Price (US$/Dose) by Type (2025-2030)
Table 60. Global Tetanus Vaccine (Adsorbed) Sales (K Dose) by Application (2019-2024)
Table 61. Global Tetanus Vaccine (Adsorbed) Sales (K Dose) by Application (2025-2030)
Table 62. Global Tetanus Vaccine (Adsorbed) Sales Market Share by Application (2019-2024)
Table 63. Global Tetanus Vaccine (Adsorbed) Sales Market Share by Application (2025-2030)
Table 64. Global Tetanus Vaccine (Adsorbed) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Tetanus Vaccine (Adsorbed) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Application (2019-2024)
Table 67. Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Application (2025-2030)
Table 68. Global Tetanus Vaccine (Adsorbed) Price (US$/Dose) by Application (2019-2024)
Table 69. Global Tetanus Vaccine (Adsorbed) Price (US$/Dose) by Application (2025-2030)
Table 70. Sanofi Pasteur Company Information
Table 71. Sanofi Pasteur Description and Business Overview
Table 72. Sanofi Pasteur Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. Sanofi Pasteur Tetanus Vaccine (Adsorbed) Product
Table 74. Sanofi Pasteur Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. GSK Tetanus Vaccine (Adsorbed) Product
Table 79. GSK Recent Developments/Updates
Table 80. Bio Farma Company Information
Table 81. Bio Farma Description and Business Overview
Table 82. Bio Farma Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. Bio Farma Tetanus Vaccine (Adsorbed) Product
Table 84. Bio Farma Recent Developments/Updates
Table 85. Serum Institute of India Company Information
Table 86. Serum Institute of India Description and Business Overview
Table 87. Serum Institute of India Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. Serum Institute of India Tetanus Vaccine (Adsorbed) Product
Table 89. Serum Institute of India Recent Developments/Updates
Table 90. Panacea Biotec Company Information
Table 91. Panacea Biotec Description and Business Overview
Table 92. Panacea Biotec Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 93. Panacea Biotec Tetanus Vaccine (Adsorbed) Product
Table 94. Panacea Biotec Recent Developments/Updates
Table 95. Mitsubishi Tanabe Pharma Company Information
Table 96. Mitsubishi Tanabe Pharma Description and Business Overview
Table 97. Mitsubishi Tanabe Pharma Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 98. Mitsubishi Tanabe Pharma Tetanus Vaccine (Adsorbed) Product
Table 99. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 100. KM Biologics Company Information
Table 101. KM Biologics Description and Business Overview
Table 102. KM Biologics Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 103. KM Biologics Tetanus Vaccine (Adsorbed) Product
Table 104. KM Biologics Recent Developments/Updates
Table 105. MassBiologics Company Information
Table 106. MassBiologics Description and Business Overview
Table 107. MassBiologics Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 108. MassBiologics Tetanus Vaccine (Adsorbed) Product
Table 109. MassBiologics Recent Developments/Updates
Table 110. Chengdu Oulin Biological Company Information
Table 111. Chengdu Oulin Biological Description and Business Overview
Table 112. Chengdu Oulin Biological Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 113. Chengdu Oulin Biological Tetanus Vaccine (Adsorbed) Product
Table 114. Chengdu Oulin Biological Recent Developments/Updates
Table 115. Hualan Biological Bacterin Company Information
Table 116. Hualan Biological Bacterin Description and Business Overview
Table 117. Hualan Biological Bacterin Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 118. Hualan Biological Bacterin Tetanus Vaccine (Adsorbed) Product
Table 119. Hualan Biological Bacterin Recent Developments/Updates
Table 120. Wuhan Biological Products Company Information
Table 121. Wuhan Biological Products Description and Business Overview
Table 122. Wuhan Biological Products Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 123. Wuhan Biological Products Tetanus Vaccine (Adsorbed) Product
Table 124. Wuhan Biological Products Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Tetanus Vaccine (Adsorbed) Distributors List
Table 128. Tetanus Vaccine (Adsorbed) Customers List
Table 129. Tetanus Vaccine (Adsorbed) Market Trends
Table 130. Tetanus Vaccine (Adsorbed) Market Drivers
Table 131. Tetanus Vaccine (Adsorbed) Market Challenges
Table 132. Tetanus Vaccine (Adsorbed) Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Tetanus Vaccine (Adsorbed)
Figure 2. Global Tetanus Vaccine (Adsorbed) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Tetanus Vaccine (Adsorbed) Market Share by Type: 2023 & 2030
Figure 4. Tetanus Vaccine Product Picture
Figure 5. Combined Vaccine Product Picture
Figure 6. Global Tetanus Vaccine (Adsorbed) Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Tetanus Vaccine (Adsorbed) Market Share by Application: 2023 & 2030
Figure 8. Children
Figure 9. Teenager
Figure 10. Adult
Figure 11. Global Tetanus Vaccine (Adsorbed) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Tetanus Vaccine (Adsorbed) Market Size (2019-2030) & (US$ Million)
Figure 13. Global Tetanus Vaccine (Adsorbed) Sales (2019-2030) & (K Dose)
Figure 14. Global Tetanus Vaccine (Adsorbed) Average Price (US$/Dose) & (2019-2030)
Figure 15. Tetanus Vaccine (Adsorbed) Report Years Considered
Figure 16. Tetanus Vaccine (Adsorbed) Sales Share by Manufacturers in 2023
Figure 17. Global Tetanus Vaccine (Adsorbed) Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Tetanus Vaccine (Adsorbed) Players: Market Share by Revenue in Tetanus Vaccine (Adsorbed) in 2023
Figure 19. Tetanus Vaccine (Adsorbed) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Tetanus Vaccine (Adsorbed) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Tetanus Vaccine (Adsorbed) Sales Market Share by Country (2019-2030)
Figure 22. North America Tetanus Vaccine (Adsorbed) Revenue Market Share by Country (2019-2030)
Figure 23. United States Tetanus Vaccine (Adsorbed) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Tetanus Vaccine (Adsorbed) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Tetanus Vaccine (Adsorbed) Sales Market Share by Country (2019-2030)
Figure 26. Europe Tetanus Vaccine (Adsorbed) Revenue Market Share by Country (2019-2030)
Figure 27. Germany Tetanus Vaccine (Adsorbed) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Tetanus Vaccine (Adsorbed) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Tetanus Vaccine (Adsorbed) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Tetanus Vaccine (Adsorbed) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Tetanus Vaccine (Adsorbed) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Tetanus Vaccine (Adsorbed) Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Tetanus Vaccine (Adsorbed) Revenue Market Share by Region (2019-2030)
Figure 34. China Tetanus Vaccine (Adsorbed) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Tetanus Vaccine (Adsorbed) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Tetanus Vaccine (Adsorbed) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Tetanus Vaccine (Adsorbed) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Tetanus Vaccine (Adsorbed) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Tetanus Vaccine (Adsorbed) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Tetanus Vaccine (Adsorbed) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Tetanus Vaccine (Adsorbed) Sales Market Share by Country (2019-2030)
Figure 42. Mexico Tetanus Vaccine (Adsorbed) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Tetanus Vaccine (Adsorbed) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Tetanus Vaccine (Adsorbed) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Tetanus Vaccine (Adsorbed) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Tetanus Vaccine (Adsorbed) Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Tetanus Vaccine (Adsorbed) Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Tetanus Vaccine (Adsorbed) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Tetanus Vaccine (Adsorbed) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Tetanus Vaccine (Adsorbed) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Tetanus Vaccine (Adsorbed) by Type (2019-2030)
Figure 52. Global Revenue Market Share of Tetanus Vaccine (Adsorbed) by Type (2019-2030)
Figure 53. Global Tetanus Vaccine (Adsorbed) Price (US$/Dose) by Type (2019-2030)
Figure 54. Global Sales Market Share of Tetanus Vaccine (Adsorbed) by Application (2019-2030)
Figure 55. Global Revenue Market Share of Tetanus Vaccine (Adsorbed) by Application (2019-2030)
Figure 56. Global Tetanus Vaccine (Adsorbed) Price (US$/Dose) by Application (2019-2030)
Figure 57. Tetanus Vaccine (Adsorbed) Value Chain
Figure 58. Tetanus Vaccine (Adsorbed) Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
